Remdesivir use may be managed by government

The recommendations come as four Indian drug companies, Cipla, Hetero, Mylan and Jubilant, gear up to get an approval for the drug in the treatment of Covid-19.

from Industry-Economic Times
Read The Rest:economictimes...